ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Update

ASP Isotopes Inc. (NASDAQ:ASPI) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 6,770,000 shares, an increase of 13.8% from the December 15th total of 5,950,000 shares. Based on an average daily trading volume, of 5,090,000 shares, the days-to-cover ratio is currently 1.3 days. Approximately 14.6% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th. Canaccord Genuity Group began coverage on ASP Isotopes in a research note on Friday, October 4th. They set a “buy” rating and a $4.50 target price on the stock.

ASP Isotopes Stock Up 10.1 %

NASDAQ:ASPI opened at $5.66 on Monday. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. ASP Isotopes has a twelve month low of $1.86 and a twelve month high of $9.33. The company has a market cap of $404.07 million, a PE ratio of -9.28 and a beta of 3.48. The company’s 50 day moving average is $5.51 and its two-hundred day moving average is $4.09.

Hedge Funds Weigh In On ASP Isotopes

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in ASP Isotopes during the 3rd quarter valued at approximately $6,249,000. Telemark Asset Management LLC acquired a new stake in ASP Isotopes during the 3rd quarter worth about $4,726,000. Philadelphia Financial Management of San Francisco LLC raised its stake in shares of ASP Isotopes by 158.3% during the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock valued at $2,757,000 after buying an additional 607,893 shares during the last quarter. Marshall Wace LLP raised its stake in shares of ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after buying an additional 433,734 shares during the last quarter. Finally, GSA Capital Partners LLP lifted its holdings in shares of ASP Isotopes by 96.0% in the 3rd quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock valued at $2,143,000 after buying an additional 377,721 shares during the period. Hedge funds and other institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.